Science, Computers & Technology Health Civil Remedies

Pharmaceutical Industry False Claims Act (FCA) FDA Healthcare Medical Devices Prescription Drugs Preliminary Injunctions PHI Biosimilars Data Breach Qui Tam DOJ Settlement BPCIA HHS HIPAA Pharmaceutical Patents Generic Drugs Medicare Amgen Appeals Hospitals Medicaid Whistleblowers Patent Infringement Patents Class Action Damages Data Protection Pharmacies Sandoz v Amgen Affordable Care Act OCR Physicians Anti-Kickback Statute First Amendment Off-Label Promotion OIG Popular Sandoz Amarin Biologics Calculation of Damages Canada Commercial Marketing Compliance FDA Approval FDCA Fraud Health Care Providers Kickbacks Patent Litigation Punitive Damages Relators SCOTUS Actavis Inc. Antitrust Litigation Apotex Civil Monetary Penalty Competition Declaratory Judgments Drug Approvals Electronic Medical Records Eli Lilly First-to-File Free Speech Health Information Technologies HONI Johnson & Johnson Life Sciences Manufacturers Marketing Negligence Nursing Homes Omnicare Patent Invalidity Personally Identifiable Information Sealed Records Stark Law State Medical Board Summary Judgment Telemedicine Advertising Anti-Competitive Attorney Generals Bristol-Myers Squibb Class Certification Clinical Laboratories CMIA CMS Covered Entities Cybersecurity Disgorgement Enforcement Actions False Statements Final Rules FTC Government Investigations Health Insurance In-Person Exam Inter Partes Review (IPR) Proceeding Irreparable Harm Jurisdiction Jury Verdicts Medical Records Medicare Part D Medtronic Misbranding Mobile Devices Monopolization Mylan Pharmaceuticals Off-Label Use Orphan Drugs Patent Dance Patented Medicines Patient Confidentiality Breaches PHRMA PMNOC Regulations Preemption Public Disclosure Rebates Remuneration Section 340B Section 8 Settlement Agreements Sherman Act Standard of Care Standing Teva Pharmaceuticals Transvaginal Mesh Abbott Laboratories AbbVie Abuse of Discretion Abuse of Power Acquisitions Administrative Authority Administrative Remedies Admissible Evidence Ambulance Providers America Invents Act ANDA Anthem Blue Cross Anticompetitive Agreements Antitrust Injuries Antitrust Investigations Antitrust Violations App Developers Apportionment AstraZeneca Avandia BMW Boston Scientific Brand Name Prescription Drugs Breach of Contract Business Records CA Supreme Court CETA China Chiropractors CIGNA Commercial Speech Commonality Concentra Consent Order Constitutional Challenges Corrective Actions Cost-Sharing Counterclaims Criminal Prosecution Cross-Appeals Cyber Attacks Data Theft Debt Collection Declaratory Rulings Deductibles Department of Health and Human Services DePuy Hip Replacement Design Defects Destruction of Evidence Disclosure Dismissals Dispute Resolution Drug & Alcohol Abuse Drug Pricing Duty to Warn Elder Abuse Enablement Inquiries Encryption Estoppel Ethicon EU Evidence Expert Testimony Failure To Warn False Billing FCRA Federal Contractors Federal Rules of Civil Procedure FERA FFDCA Financial Conduct Authority (FCA) Fines First Impression France Frivolous Lawsuits FTC Act Genentech GlaxoSmithKline Hackers Halifax Hospital Halliburton Hart-Scott-Rodino Act Hatch-Waxman Health Canada Health Insurance Exchanges Healthcare Fraud Hearsay Hearsay Exceptions HIPAA Audits HIPAA Breach HIPAA Omnibus Rule HITECH HRSA Humana Identity Theft Indictments Infectious Diseases Innovation Innovator Liability Invasion of Privacy IP License Janssen Pharmaceuticals Judicial Review Labeling Learned Intermediary Loss Mitigation Lost Profits MACs Malfeasance Managed Care Contracts Mass Tort Litigation Media Medical Foods Medicare Advantage MedQuest Mental Health Merck Motion to Amend Multidistrict Litigation Multinationals Neglect Negligent Misrepresentation New Legislation NIH Notice Provisions Notice Requirements Obviousness Opioid Orange Book Overpayment OxyContin Patent Prosecution Patent Trial and Appeal Board Patented Medicine Prices Review Board (PMPRB) Penalties Permanent Injunctions Personal Liability Personalized Medicine Pfizer PHSA Physician Medicare Reimbursements Post-Grant Review Precision Medicine Initiative (PMI) Prescribing Authority Prescription Drug Coverage Pretext Prior Art Proctor & Gamble Product Exclusivity Product Hopping Professional Liability Proposed Legislation Public Interest QCA Healthplan Radiopharmaceuticals Refill Reminders Reporting Requirements Retaliation Rulemaking Process Safe Harbors SEC Section 5 Securities Litigation Self-Referral Sexual Harassment Shareholder Litigation State Law Claims Stem cells STRONG Patents Act Supervision Sutter Health Telehealth Theft Trade Agreements TRICARE Unfair Competition Universal Health Services Inc v United States ex rel Escobar USPTO Vaccinations Wells Fargo Wrongful Death WSLA